FDA Center for Drug Evaluation & Research Issues Warning Letter to Eugia Pharma Specialities
August 19, 2026
August 19, 2026
WASHINGTON, Aug. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Eugia Pharma Specialities Limited from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Yugandhar Puvvala, CEO & Executive Director, Eugia Pharma Specialities Limited, Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad 500032 Telangana . . .
* * *
Recipient: Mr. Yugandhar Puvvala, CEO & Executive Director, Eugia Pharma Specialities Limited, Galaxy, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad 500032 Telangana . . .